Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion type Assertion NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_head.
- NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion wasGeneratedBy ECO_0000203 NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_provenance.
- NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion wasDerivedFrom befree-20140225 NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_provenance.
- NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion SIO_000772 16928730 NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_provenance.
- NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion evidence source_evidence_literature NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_provenance.
- NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_assertion description "[In the group with the lowest risk of overt nephropathy (n = 340), the ACE D polymorphism increased overt nephropathy risk twofold (p = 0.05), whereas a protective effect was observed for the LIPC CC genotype (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508205.RAghgt7iOMcX9uiT1kr_iEvq-C6pmiR9tm5_ZD0rUwNpg130_provenance.